{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:14:39Z","timestamp":1792671279844,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T00:00:00Z","timestamp":1710115200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","award":["5057\/5058"],"award-info":[{"award-number":["5057\/5058"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000615","name":"Fight for Sight UK","doi-asserted-by":"publisher","award":["5105\/5106"],"award-info":[{"award-number":["5105\/5106"]}],"id":[{"id":"10.13039\/501100000615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ70047"],"award-info":[{"award-number":["2023JJ70047"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2021JJ4002"],"award-info":[{"award-number":["2021JJ4002"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"UKRI Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W004682\/1"],"award-info":[{"award-number":["MR\/W004682\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.coph.2024.102448","type":"journal-article","created":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T00:31:28Z","timestamp":1711758688000},"page":"102448","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["The complement pathway as a therapeutic target for neovascular age-related macular degeneration-mediated subretinal fibrosis"],"prefix":"10.1016","volume":"76","author":[{"given":"Heping","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caijiao","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2024.102448_bib1","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","article-title":"Age-related macular degeneration","volume":"392","author":"Mitchell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2024.102448_bib2","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1172\/JCI71029","article-title":"Recent developments in the treatment of age-related macular degeneration","volume":"124","author":"Holz","year":"2014","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.coph.2024.102448_sref3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ajo.2022.09.008","article-title":"Review of fibrosis in neovascular age-related macular degeneration","volume":"246","author":"Cheong","year":"2023","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.coph.2024.102448_bib4","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/IAE.0000000000002779","article-title":"Prevalence and risk factros for the development of physician-graded subretinal fibrosis in eyes treated for neovascular age-related macular degeneration","volume":"40","author":"Teo","year":"2020","journal-title":"Retina"},{"key":"10.1016\/j.coph.2024.102448_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ebiom.2018.11.029","article-title":"Myofibroblasts in macular fibrosis secondary to neovascular age-related macular degeneration-the potential sources and molecular cues for their recruitment and activation","volume":"38","author":"Little","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.coph.2024.102448_bib6","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/ceo.13742","article-title":"Ten-year outcomes of anti-vascular endothelial growth factor treatment for neovascular age-related macular disease: a single-centre French study","volume":"48","author":"Wolff","year":"2020","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.coph.2024.102448_bib7","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.ophtha.2018.01.004","article-title":"Development and course of scars in the Comparison of age-related macular degeneration treatments trials","volume":"125","author":"Daniel","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2024.102448_bib8","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.oret.2019.06.002","article-title":"The evolution of fibrosis and atrophy and their relationship with visual outcomes in asian persons with neovascular age-related macular degeneration","volume":"3","author":"Cheung","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.coph.2024.102448_sref9","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1111\/aos.14905","article-title":"The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world","volume":"100","author":"Llorente-Gonz\u00e1lez","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.coph.2024.102448_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/aos.14183","article-title":"Real-world 10-year experiences with intravitreal treatment\u00a0with ranibizumab and aflibercept for neovascular age-related macular degeneration","volume":"98","author":"Brynskov","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.coph.2024.102448_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0002-9394(14)71859-8","article-title":"Immunohistochemical and histochemical properties of surgically excised subretinal neovascular membranes in age-related macular degeneration","volume":"114","author":"Grossniklaus","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.coph.2024.102448_bib12","first-page":"119","article-title":"Macrophage and retinal pigment epithelium expression of angiogenic cytokines in choroidal neovascularization","volume":"8","author":"Grossniklaus","year":"2002","journal-title":"Molecular vision"},{"key":"10.1016\/j.coph.2024.102448_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/srep16754","article-title":"Alterations in circulating immune cells in neovascular age-related macular degeneration","volume":"5","author":"Lechner","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.coph.2024.102448_bib14","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12979-020-00205-w","article-title":"Plasma level of lipocalin 2 is increased in neovascular age-related macular degeneration patients, particularly those with macular fibrosis","volume":"17","author":"Chen","year":"2020","journal-title":"Immun Ageing"},{"key":"10.1016\/j.coph.2024.102448_bib15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12974-017-0820-y","article-title":"Peripheral blood mononuclear cells from neovascular age-related macular degeneration patients produce higher levels of chemokines CCL2 (MCP-1) and CXCL8 (IL-8)","volume":"14","author":"Lechner","year":"2017","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.coph.2024.102448_bib16","doi-asserted-by":"crossref","DOI":"10.1186\/s12979-016-0060-5","article-title":"Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration: complement activation in AMD","volume":"13","author":"Lechner","year":"2016","journal-title":"Immun Ageing : I & A"},{"key":"10.1016\/j.coph.2024.102448_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajo.2012.01.036","article-title":"Altered expression of CD46 and CD59 on leukocytes in neovascular age-related macular degeneration","volume":"154","author":"Singh","year":"2012","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.coph.2024.102448_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12974-023-02731-y","article-title":"Old age promotes retinal fibrosis in choroidal neovascularization through circulating fibrocytes and profibrotic macrophages","volume":"20","author":"Yi","year":"2023","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.coph.2024.102448_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/mi.2008.27","article-title":"R\u00a0C: immune privilege or privileged immunity?","volume":"1","author":"Forrester","year":"2008","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.coph.2024.102448_bib20","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0042-6989(01)00185-7","article-title":"Immunobiology and privilege of neuronal retina and pigment epithelium transplants","volume":"42","author":"Streilein","year":"2002","journal-title":"Vis Res"},{"key":"10.1016\/j.coph.2024.102448_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.preteyeres.2018.10.003","article-title":"Immune regulation in the aging retina","volume":"69","author":"Chen","year":"2019","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.coph.2024.102448_bib22","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.preteyeres.2009.06.001","article-title":"Para-inflammation in the aging retina","volume":"28","author":"Xu","year":"2009","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.coph.2024.102448_bib23","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/archopht.126.7.941","article-title":"Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration","volume":"126","author":"Chang","year":"2008","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.coph.2024.102448_bib24","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.oret.2021.05.015","article-title":"Etiology, treatment patterns, and outcomes for choroidal neovascularization in the pediatric population: an intelligent research in Sight (IRIS\u00ae) registry study","volume":"6","author":"Finn","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.coph.2024.102448_bib25","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-020-02033-7","article-title":"Macrophage to myofibroblast transition contributes to subretinal fibrosis secondary to neovascular age-related macular degeneration","volume":"17","author":"Little","year":"2020","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.coph.2024.102448_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","article-title":"Muller cells in the healthy and diseased retina","volume":"25","author":"Bringmann","year":"2006","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.coph.2024.102448_bib27","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1167\/iovs.65.2.42","article-title":"M\u00fcller glial cells in the macula: their activation and cell-cell interactions in age-related macular degeneration","volume":"65","author":"Navneet","year":"2024","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.coph.2024.102448_bib28","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nri2620","article-title":"Complement regulators and inhibitory proteins","volume":"9","author":"Zipfel","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.coph.2024.102448_sref29","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","article-title":"A guide to complement biology, pathology and therapeutic opportunity","volume":"24","author":"Mastellos","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coph.2024.102448_bib30","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejphar.2016.03.001","article-title":"Targeting the complement system for the management of retinal inflammatory and degenerative diseases","volume":"787","author":"Xu","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2024.102448_bib31","first-page":"1588","article-title":"Complement gene expression and regulation in mouse retina and retinal pigment epithelium\/choroid","volume":"17","author":"Luo","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.coph.2024.102448_bib32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.preteyeres.2009.11.003","article-title":"The pivotal role of the complement system in aging and age-related macular degeneration: hypothesis re-visited","volume":"29","author":"Anderson","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.coph.2024.102448_bib33","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41581-023-00704-1","article-title":"Complosome - the intracellular complement system","volume":"19","author":"West","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.coph.2024.102448_bib34","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.immuni.2013.10.018","article-title":"Intracellular complement activation sustains T cell homeostasis and mediates effector differentiation","volume":"39","author":"Liszewski","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2024.102448_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3109\/09273948.2011.628432","article-title":"Genetics of immunological and inflammatory components in age-related macular degeneration","volume":"20","author":"Tuo","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.coph.2024.102448_bib36","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molimm.2015.02.032","article-title":"Age-related macular degeneration and the role of the complement system","volume":"67","author":"McHarg","year":"2015","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coph.2024.102448_bib37","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1073\/pnas.0408835103","article-title":"Drusen complement components C3a and C5a promote choroidal neovascularization","volume":"103","author":"Nozaki","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coph.2024.102448_bib38","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/eye.2001.142","article-title":"Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in\u00a0drusen\u00a0biogenesis","volume":"15","author":"Mullins","year":"2001","journal-title":"Eye (London, England)"},{"key":"10.1016\/j.coph.2024.102448_sref39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/hmg\/ddab256","article-title":"Systemic complement levels in patients with age-related macular degeneration carrying rare or low-frequency variants in the CFH gene","volume":"31","author":"de Jong","year":"2022","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.coph.2024.102448_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/32b9bc31-ed6d-4d31-9ce0-480407017bad","article-title":"Systemic complement activation in age-related macular degeneration","volume":"3","author":"Scholl","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2024.102448_bib41","doi-asserted-by":"crossref","first-page":"33826","DOI":"10.1074\/jbc.M110.153130","article-title":"Recombinant membrane-targeted form of CD59 inhibits the growth of choroidal neovascular complex in mice","volume":"285","author":"Bora","year":"2010","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2024.102448_bib42","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1167\/iovs.08-2222","article-title":"A\u00a0targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration","volume":"50","author":"Rohrer","year":"2009","journal-title":"Investigative ophthalmology & visual science"},{"key":"10.1016\/j.coph.2024.102448_bib43","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.4049\/jimmunol.178.3.1783","article-title":"CD59, a complement regulatory protein, controls choroidal neovascularization in a mouse model of wet-type age-related macular degeneration","volume":"178","author":"Bora","year":"2007","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.coph.2024.102448_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic\u00a0atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2024.102448_bib45","article-title":"Complement inhibitors for age-related macular degeneration","volume":"6","author":"Tzoumas","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.coph.2024.102448_bib46","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.coph.2024.102448_sref47","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s12974-022-02546-3","article-title":"Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells","volume":"19","author":"Llori\u00e1n-Salvador","year":"2022","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.coph.2024.102448_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1236495","article-title":"A\u00a0role for the terminal C5-C9 complement pathway in idiopathic pulmonary fibrosis","volume":"10","author":"Sikkeland","year":"2023","journal-title":"Front Med"},{"key":"10.1016\/j.coph.2024.102448_bib49","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbrc.2022.02.090","article-title":"Complement protein C1q activates lung fibroblasts and exacerbates silica-induced pulmonary fibrosis in mice","volume":"603","author":"Ogawa","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2024.102448_sref50","doi-asserted-by":"crossref","first-page":"2880","DOI":"10.1111\/bph.15408","article-title":"Role of intracellular complement activation in kidney fibrosis","volume":"178","author":"Portilla","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2024.102448_bib51","doi-asserted-by":"crossref","first-page":"F1171","DOI":"10.1152\/ajprenal.00165.2019","article-title":"Complement C3 exacerbates renal interstitial fibrosis by facilitating the M1 macrophage phenotype in a mouse model of unilateral ureteral obstruction","volume":"317","author":"Cui","year":"2019","journal-title":"Am J Physiol Ren Physiol"},{"key":"10.1016\/j.coph.2024.102448_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110604","article-title":"Immunoglobulin A and complement C4 are involved in the progression of liver fibrosis in patients with chronic hepatitis B","volume":"122","author":"Zhang","year":"2023","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.coph.2024.102448_bib53","article-title":"Immune cells in subretinal wound healing and fibrosis","volume":"16","author":"Szczepan","year":"2022","journal-title":"Forontiers in Cellular Neuroscience"},{"key":"10.1016\/j.coph.2024.102448_bib54","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3389\/fimmu.2018.02385","article-title":"Complement C3 produced by macrophages promotes renal fibrosis via IL-17a secretion","volume":"9","author":"Liu","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2024.102448_bib55","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.3389\/fimmu.2018.01002","article-title":"Complement activation during ischemia\/reperfusion injury induces pericyte-to-myofibroblast transdifferentiation regulating peritubular capillary lumen reduction through pERK signaling","volume":"9","author":"Castellano","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2024.102448_bib56","doi-asserted-by":"crossref","first-page":"31189","DOI":"10.1074\/jbc.M115.671180","article-title":"Complement component C5a primes retinal pigment epithelial cells for inflammasome activation by lipofuscin-mediated photooxidative damage","volume":"290","author":"Brandstetter","year":"2015","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.coph.2024.102448_bib57","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3389\/fimmu.2020.00883","article-title":"The role of NLRP3 inflammasome activation in the epithelial to mesenchymal transition process during the fibrosis","volume":"11","author":"Alyaseer","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2024.102448_sref58","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.immuni.2021.03.003","article-title":"The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts","volume":"54","author":"Fri\u0161\u010di\u0107","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2024.102448_bib59","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1080\/14656566.2023.2257604","article-title":"The complement system: a novel therapeutic target for age-related macular degeneration","volume":"24","author":"Shughoury","year":"2023","journal-title":"Expet Opin Pharmacother"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489224000183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489224000183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T19:50:26Z","timestamp":1778615426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489224000183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":59,"alternative-id":["S1471489224000183"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2024.102448","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complement pathway as a therapeutic target for neovascular age-related macular degeneration-mediated subretinal fibrosis","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2024.102448","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102448"}}